Home
About
About
Management
Board of Directors
Scientific Advisory Board
Protein Antibacterials
Protein Antibacterials
Bacteriocins
Lysins
Ectolysin
P128
Pipeline
Bacteriophages
Bacteriophages
Novel
Applications
Services
Services
Collaborative Research
Media
In The News
Posters and
Presentations
Publications
Contact
Contact
Business Development
and Licensing
Careers
Office Location
News
CARB-X is Funding GangaGen Biotechnologies to Develop a New Drug to Treat Pneumonia Caused by Multidrug-Resistant Klebsiella Pneumoniae Bacteria
October 4, 2020
Back to Top